Company news

AstraZeneca PLC news in 2026

AstraZeneca PLC's news releases, calls and decks from 2026, newest first.

View company

AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca

January 18, 2026

Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences

January 14, 2026

Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale

January 13, 2026

TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer

January 13, 2026

AZN new Head of Investor Relations Joris Silon

January 8, 2026

BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development

January 6, 2026

← Newer news releases

Calls in 2026

Decks in 2026